Free Trial

Nanobiotix (NASDAQ:NBTX) Trading Down 6.8% - Here's What Happened

Nanobiotix logo with Medical background

Nanobiotix S.A. (NASDAQ:NBTX - Get Free Report)'s share price fell 6.8% on Thursday . The company traded as low as $3.18 and last traded at $3.28. 55,693 shares were traded during mid-day trading, an increase of 174% from the average session volume of 20,299 shares. The stock had previously closed at $3.52.

Analyst Upgrades and Downgrades

Separately, Guggenheim assumed coverage on shares of Nanobiotix in a report on Wednesday, August 28th. They issued a "buy" rating and a $12.00 target price on the stock.

Get Our Latest Report on Nanobiotix

Nanobiotix Stock Performance

The business's 50-day simple moving average is $3.94 and its 200 day simple moving average is $4.78.

About Nanobiotix

(Get Free Report)

Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.

Featured Articles

Should you invest $1,000 in Nanobiotix right now?

Before you consider Nanobiotix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nanobiotix wasn't on the list.

While Nanobiotix currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines